Flibanserin — multifunctional serotonin agonist/antagonist
100 film-coated tablets × 50 mg

• Primary research use: hypoactive sexual-desire disorder (HSDD) models; improves dopamine / norepinephrine signalling in prefrontal cortex while lowering 5-HT2A tone.
• Dosing profile: 50 mg orally at bedtime to minimise dizziness & hypotension (daily administration required, unlike on-demand PDE-5 inhibitors).
• Key cautions: avoid alcohol (severe hypotension/syncope); contraindicated with potent CYP3A4 inhibitors; monitor blood pressure & liver enzymes.
• Onset & duration: therapeutic effect builds over ≥4 weeks; steady-state t_½ ≈ 11 h.
• QC: ≥ 99 % API purity (HPLC); GMP tablet press; tamper-evident cap with scratch-code authenticity.